97 related articles for article (PubMed ID: 7706130)
1. Antitumor activity of cytogenin.
Kumagai H; Masuda T; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1995 Feb; 48(2):175-8. PubMed ID: 7706130
[TBL] [Abstract][Full Text] [Related]
2. Modulation of macrophage activity in tumor bearing mice by cytogenin.
Kumagai H; Masuda T; Sakashita M; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1995 Apr; 48(4):321-5. PubMed ID: 7775270
[TBL] [Abstract][Full Text] [Related]
3. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
Oikawa T; Sasaki M; Inose M; Shimamura M; Kuboki H; Hirano S; Kumagai H; Ishizuka M; Takeuchi T
Anticancer Res; 1997; 17(3C):1881-6. PubMed ID: 9216639
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and cytotoxicity of a new ankinomycin derivative, 3'-,11-dibutyryl ankinomycin.
Ishii S; Satoh Y; Tsuruo T
Cancer Chemother Pharmacol; 1993; 32(3):173-8. PubMed ID: 8500220
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of polysaccharide grifolan NMF-5N on syngeneic tumor in mice.
Suzuki I; Takeyama T; Ohno N; Oikawa S; Sato K; Suzuki Y; Yadomae T
J Pharmacobiodyn; 1987 Feb; 10(2):72-7. PubMed ID: 3598845
[TBL] [Abstract][Full Text] [Related]
7. Effect of conagenin in tumor bearing mice. Antitumor activity, generation of effector cells and cytokine production.
Kawatsu M; Yamashita T; Osono M; Masuda T; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1993 Nov; 46(11):1692-8. PubMed ID: 8270491
[TBL] [Abstract][Full Text] [Related]
8. Host-mediated antitumor effect of grifolan NMF-5N, a polysaccharide obtained from Grifola frondosa.
Takeyama T; Suzuki I; Ohno N; Oikawa S; Sato K; Ohsawa M; Yadomae T
J Pharmacobiodyn; 1987 Nov; 10(11):644-51. PubMed ID: 3446772
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of kigamicin D on mouse tumor models.
Masuda T; Ohba S; Kawada M; Osono M; Ikeda D; Esumi H; Kunimoto S
J Antibiot (Tokyo); 2006 Apr; 59(4):209-14. PubMed ID: 16830887
[TBL] [Abstract][Full Text] [Related]
10. Distinct antitumor mechanisms of recombinant interleukin-2 on recombinant interleukin-2-activated killer-sensitive and -resistant murine tumors.
Maekawa R; Kitagawa T; Koizumi K; Sato K; Homma M
J Biol Response Mod; 1989 Dec; 8(6):676-90. PubMed ID: 2600605
[TBL] [Abstract][Full Text] [Related]
11. Effects of cytogenin on spontaneous arthritis in MRL/1 mice and on pristane-induced arthritis (PIA) in DBA/1J mice.
Abe C; Hirano S; Wakazono K; Mase T; Yamamoto R; Matsufuji M; Sakata N; Agata N; Iguchi H; Ishizuka M
Int J Tissue React; 1995; 17(5-6):175-80. PubMed ID: 8835627
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activities of KW-2152, a new isoquinon agent, against human tumor xenografts transplanted into nude mice.
Nosoh Y; Nishiyama M; Niimi K; Hirabayashi N; Toge T; Niimoto M; Hattori T
Jpn J Surg; 1987 Mar; 17(2):146-9. PubMed ID: 3626206
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
14. Antitumor cells found in tumor-bearing mice given ubenimex.
Ishizuka M; Masuda T; Mizutani S; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1987 May; 40(5):697-701. PubMed ID: 3497141
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytogenin, a novel immunomodulator, on streptozotocin-induced diabetes in mice.
Kumagai H; Wakazono K; Agata N; Isshiki K; Ishizuka M; Ikeda D
J Antibiot (Tokyo); 2005 Mar; 58(3):202-5. PubMed ID: 15895529
[TBL] [Abstract][Full Text] [Related]
16. Host-mediated antitumor effect of DMG, a degraded D-manno-D-glucan from Microellobosporia grisea culture fluid.
Nakajima H; Hashimoto S; Nagao S; Kita Y; Khono M; Ogawa H; Abe S; Mizuno D
Gan; 1984 Mar; 75(3):253-9. PubMed ID: 6233200
[TBL] [Abstract][Full Text] [Related]
17. Cytogenin, a novel antitumor substance.
Kumagai H; Masuda T; Ohsono M; Hattori S; Naganawa H; Sawa T; Hamada M; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1990 Nov; 43(11):1505-7. PubMed ID: 2272926
[No Abstract] [Full Text] [Related]
18. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
De Ruysscher D; Sobis H; Vandeputte M; Waer M
J Immunol; 1991 Jun; 146(12):4065-70. PubMed ID: 1828259
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a new antibiotic, kazusamycin.
Komiyama K; Okada K; Hirokawa Y; Masuda K; Tomisaka S; Umezawa I
J Antibiot (Tokyo); 1985 Feb; 38(2):224-9. PubMed ID: 3922935
[TBL] [Abstract][Full Text] [Related]
20. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
Ishida N; Saito M; Nanjo M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
